Publications | Page 7 | Cervo Brain Research Centre

Export 8 results:

Filters: Author is Picher-Martel, Vincent [Clear All Filters]

2023

“Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis.”, Int J Mol Sci, vol. 24, no. 6, 2023.

2021

S. Sampath Thammisetty, Renaud, L., Picher-Martel, V., Weng, Y. Cheng, Calon, F., Saikali, S., J-P Julien, and Kriz, J., “Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion.”, Neurotherapeutics, vol. 18, no. 2, pp. 1095-1112, 2021.

2020

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid”, Acta neuropathologica communications, vol. 8, no. 1, pp. 65 - 65, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid.”, Acta Neuropathol Commun, vol. 8, no. 1, p. 65, 2020.

2019

L. Renaud, Picher-Martel, V., Codron, P., and J-P Julien, “Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.”, Acta Neuropathol Commun, vol. 7, no. 1, p. 103, 2019.

2018

V. Picher-Martel, Renaud, L., Bareil, C., and J-P Julien, “Neuronal Expression of UBQLN2 Exacerbates TDP-43 Pathology in TDP-43 Mice through Interaction with Ubiquitin.”, Mol Neurobiol, 2018.

2016

V. Picher-Martel, Valdmanis, P. N., Gould, P. V., J-P Julien, and Dupré, N., “From animal models to human disease: a genetic approach for personalized medicine in ALS.”, Acta Neuropathol Commun, vol. 4, no. 1, p. 70, 2016.

2015

V. Picher-Martel, Dutta, K., Phaneuf, D., Sobue, G., and J-P Julien, “Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells.”, Mol Brain, vol. 8, no. 1, p. 71, 2015.

Funding / Support / Partners

© Gouvernement du Québec